• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The influence of guided imagery on chemotherapy-related nausea and vomiting.

作者信息

Troesch L M, Rodehaver C B, Delaney E A, Yanes B

机构信息

Arthur G. James Cancer Hospital and Research Institute, Ohio State University, Columbus.

出版信息

Oncol Nurs Forum. 1993 Sep;20(8):1179-85.

PMID:8415147
Abstract

The purpose of this study was to determine if the addition of guided imagery to a standard antiemetic regimen decreased nausea, vomiting, and retching occurrence and distress in patients receiving cisplatin-based chemotherapy. A convenience sample of patients (N = 28) was selected from an oncologist's patient population and randomized into two groups. Both groups received the same standard antiemetic regimen, while the experimental group additionally used a chemotherapy-specific guided-imagery audiotape. The Rhodes Index of Nausea and Vomiting Form 2 was used to measure the nausea and vomiting experience. Findings revealed no statistically significant difference in this measurement between the two groups when measured at five different times during chemotherapy administration. The Chemotherapy Experience Survey was used to evaluate the participants' overall perceptions of the chemotherapy experience. The guided-imagery group expressed a significantly more positive experience (p = 0.0001) with chemotherapy. These findings have definite implications for developing effective nursing interventions to promote patient involvement in self-care practices and to increase patient coping abilities during symptom occurrence.

摘要

相似文献

1
The influence of guided imagery on chemotherapy-related nausea and vomiting.
Oncol Nurs Forum. 1993 Sep;20(8):1179-85.
2
Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.影响基于顺铂化疗中恶心和呕吐结果的参数。
Anticancer Res. 2000 Nov-Dec;20(6C):4777-83.
3
The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.口服NK(1)拮抗剂阿瑞匹坦与标准止吐药联合使用,在多周期基于顺铂的化疗中可预防恶心和呕吐:两项随机、安慰剂对照的III期临床试验的联合分析。
Eur J Cancer. 2004 Feb;40(3):403-10.
4
Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.托烷司琼(呕必停)单药及与地塞米松联合用于预防化疗引起的呕吐:北欧的经验。
Semin Oncol. 1994 Oct;21(5 Suppl 9):20-6.
5
A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.一份关于在严重呕吐情况下,将5-羟色胺3受体拮抗剂托烷司琼(呕必停)与地塞米松和胃复安的标准止吐方案用于顺铂治疗患者的比较报告。
Semin Oncol. 1994 Oct;21(5 Suppl 9):3-6.
6
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.在标准止吐药基础上加用口服NK1拮抗剂阿瑞匹坦,可在多周期顺铂化疗期间预防恶心和呕吐。
J Clin Oncol. 2003 Nov 15;21(22):4105-11. doi: 10.1200/JCO.2003.10.128. Epub 2003 Oct 14.
7
The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.地塞米松在减轻化疗引起的恶心和呕吐方面的影响。
J BUON. 2007 Apr-Jun;12(2):245-52.
8
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.确定口服NK1拮抗剂阿瑞匹坦预防化疗引起的恶心和呕吐的剂量。
Cancer. 2003 May 1;97(9):2290-300. doi: 10.1002/cncr.11320.
9
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.阿瑞匹坦、昂丹司琼和地塞米松用于接受中度致吐性化疗的中国乳腺癌患者化疗引起的恶心和呕吐的随机研究。
Breast Cancer Res Treat. 2009 Feb;113(3):529-35. doi: 10.1007/s10549-008-9957-9. Epub 2008 Mar 10.
10
Improved food intake and reduced nausea and vomiting in patients given a restricted diet while receiving cisplatin chemotherapy.在接受顺铂化疗时采用限制饮食的患者食物摄入量增加,恶心和呕吐症状减轻。
J Am Diet Assoc. 1992 Jan;92(1):58-61.

引用本文的文献

1
Guided Imagery And Progressive Muscle Relaxation as a Cluster of Symptoms Management Intervention in Patients Receiving Chemotherapy: A Randomized Control Trial.指导性意象与渐进性肌肉松弛作为化疗患者症状群管理干预措施的随机对照试验
PLoS One. 2016 Jun 24;11(6):e0156911. doi: 10.1371/journal.pone.0156911. eCollection 2016.
2
Chemotherapy-Induced Nausea and Vomiting.化疗引起的恶心和呕吐
US Oncol. 2008;4(1):19-23. doi: 10.17925/ohr.2008.04.1.19.
3
Treatment of Nausea and Vomiting During Chemotherapy.化疗期间恶心和呕吐的治疗
US Oncol Hematol. 2011;7(2):91-97. doi: 10.17925/ohr.2011.07.2.91.
4
The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy.多维运动干预对接受化疗的癌症患者身体能力、幸福感和生活质量的影响。
Support Care Cancer. 2006 Feb;14(2):116-27. doi: 10.1007/s00520-005-0864-x. Epub 2005 Aug 12.
5
Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy.针对接受化疗的癌症患者的多维运动计划的可行性、身体能力及健康益处。
Support Care Cancer. 2003 Nov;11(11):707-16. doi: 10.1007/s00520-003-0504-2. Epub 2003 Jul 24.